Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition

Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition

US Patent 6656466 · Granted Dec 2, 2003

Estimated economic value: $601,474,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for overcoming glutamine deprivation during mammalian cell culture2025
Process for the recovery of lithium and transition metal using heat2024
Electrode active material, its manufacture and use2022
Process for making cathode materials for lithium ion batteries2021
Methods for overcoming glutamine deprivation during mammalian cell culture2021
Manganese supplementation for control of glycosylation in mammalian cell culture2020
Process for making a cathode active material and a precursor therefore, cathode 2020
Control of protein glycosylation by culture medium supplementation and cell cult2020
Mixed transition metal oxides for lithium ion batteries2020
Process for making cathode materials for lithium ion batteries2019
Control of protein glycosylation by culture medium supplementation and cell cult2018
Method of supplementing culture media to prevent undesirable amino acid substitu2015